MA & Associates, LLC Completes Preliminary Review, Continues to Progress

EAST HANOVER, N.J., May 11, 2018 /PRNewswire/ -- Pazoo, Inc. (OTC: PZOO) is pleased to announce that the MA & Associates, LLC (DBA: MA Analytics) testing laboratory in Las Vegas, Nevada underwent its preliminary review given by the State last week on May 2. The lab is moving ever closer to establishing itself as an elite testing laboratory to State and locally approved Nevada customers.

Last week, the State came in to complete a preliminary review of all areas of the lab including staff, policies, procedures, and testing controls. This was one of the final steps needed before MA Analytics can be open and become revenue generating. There are only a limited number of alterations and additions to the lab that need to be made before a final review is conducted. The staff and management are working tirelessly to make the changes proposed by the State so that we can schedule the final review in the upcoming weeks.

We will announce to the public in a future press release the scheduled date of the final review as well as the results.

About Pazoo, Inc.

Pazoo, Inc. is focused on health, wellness and safety. Through our investment in MA & Associates LLC, in connection with the projected opening of the lab, Pazoo will provide industry leading laboratory testing of cannabis. Upon its opening, the lab will provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities.

Safe Harbor Statement

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

SOURCE Pazoo, Inc.

Related Links

www.pazoo.com